Therapy of allergic bronchial asthma with omalizumab – an anti-IgE monoclonal antibody

By D’Amato Gennaro  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 371-376

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

By Yalcin Arzu Didem  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1335-1341

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab for treatment of allergic rhinitis

By Vashisht Priyanka  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 6, 2013-08 ,pp. : 933-945

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab: a future innovation for treatment of severe ocular allergy?

By Williams Patricia B   Sheppard Jr John D  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 12, 2005-12 ,pp. : 1603-1609

Informa Healthcare

Access to resources Recommend Favorite

Anti-IgE – emerging opportunities for Omalizumab

By Babu K Suresh   Polosa Riccardo   Morjaria Jaymin B  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 765-777

Informa Healthcare

Access to resources Recommend Favorite